# Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome

> **NCT04056169** · PHASE4 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 50 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Carotid Atherosclerotic Plaque With Inflammation

## Interventions

- **DRUG:** high-dose rosuvastatin
- **DRUG:** low-dose rosuvastatin plus ezetimibe

## Key facts

- **NCT ID:** NCT04056169
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-29
- **Primary completion:** 2019-07-23
- **Final completion:** 2019-07-23
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04056169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04056169, "Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04056169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*